MYRIAD GENETICS, INC. (MYGN) Gross margin 2016–2025
MYRIAD GENETICS, INC. (MYGN) gross margin by fiscal year — reported gross profit divided by reported revenue.
69.9%FY2025 · since FY2016: 80.1% → 69.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 69.9% | +0.0 pp |
| FY2024 | 69.9% | +1.2 pp |
| FY2023 | 68.6% | -1.6 pp |
| FY2022 | 70.2% | — |
| FY2016 | 80.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MYGN financial trends
MYGN RevenueMYGN Net incomeMYGN Net marginMYGN Gross profitMYGN Operating incomeMYGN Operating marginMYGN Operating cash flowMYGN Free cash flowMYGN Capital expendituresMYGN Return on equityMYGN Stock buybacksMYGN Dividends paidMYGN Total assetsMYGN Total liabilitiesMYGN Shareholders’ equityMYGN overview →